Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mittelbronn

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The British Journal of Radiology|August 31, 2006
Disseminated mucormycosis in haematological patients: CT and MRI findings with pathological correlationM Horger, H Hebart, H Schimmel, et al.
Neuropathology and Applied Neurobiology|July 5, 2013
BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/gangliogliomaC Koelsche, F Sahm, W Paulus, et al.
British Journal of Cancer|August 6, 2014
Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrencesP Balermpas, F Rödel, R Liberz, et al.
Neuropathology and Applied Neurobiology|March 18, 2005
Extended pathoanatomical studies point to a consistent affection of the thalamus in spinocerebellar ataxia type 2U Rüb, D Del Turco, K Bürk, et al.
International Journal of Oncology|May 4, 2012
PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastomaM C Burger, D P Brucker, P Baumgarten, et al.
Oncogene|February 15, 2011
Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastomaG Fiaschetti, D Castelletti, S Zoller, et al.
Neuropathology and Applied Neurobiology|May 12, 2007
De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survivalM Mittelbronn, D Capper, B Bunz, et al.
Cell Death & Disease|May 18, 2013
Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approachÁ C Murphy, B Weyhenmeyer, J Schmid, et al.
Neurology|October 13, 2004
Damage to the reticulotegmental nucleus of the pons in spinocerebellar ataxia type 1, 2, and 3U Rüb, K Bürk, L Schöls, et al.
Neuropathology and Applied Neurobiology|October 15, 2013
Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosityP Baumgarten, P N Harter, M Tönjes, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The British Journal of Radiology|August 31, 2006
Disseminated mucormycosis in haematological patients: CT and MRI findings with pathological correlationM Horger, H Hebart, H Schimmel, et al.
Neuropathology and Applied Neurobiology|July 5, 2013
BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/gangliogliomaC Koelsche, F Sahm, W Paulus, et al.
British Journal of Cancer|August 6, 2014
Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrencesP Balermpas, F Rödel, R Liberz, et al.
Neuropathology and Applied Neurobiology|March 18, 2005
Extended pathoanatomical studies point to a consistent affection of the thalamus in spinocerebellar ataxia type 2U Rüb, D Del Turco, K Bürk, et al.
International Journal of Oncology|May 4, 2012
PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastomaM C Burger, D P Brucker, P Baumgarten, et al.
Oncogene|February 15, 2011
Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastomaG Fiaschetti, D Castelletti, S Zoller, et al.
Neuropathology and Applied Neurobiology|May 12, 2007
De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survivalM Mittelbronn, D Capper, B Bunz, et al.
Cell Death & Disease|May 18, 2013
Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approachÁ C Murphy, B Weyhenmeyer, J Schmid, et al.
Neurology|October 13, 2004
Damage to the reticulotegmental nucleus of the pons in spinocerebellar ataxia type 1, 2, and 3U Rüb, K Bürk, L Schöls, et al.
Neuropathology and Applied Neurobiology|October 15, 2013
Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosityP Baumgarten, P N Harter, M Tönjes, et al.
Pageof 5